AI assistant
Sending…
Sopharma AD — Earnings Release 2023
Dec 20, 2023
2543_rns_2023-12-20_24a792b5-f789-44d7-8e83-1b765237d517.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report №244/2023 Dated December 20, 2023
NOTIFICATION
"Sopharma" AD (the Company) notifies that for the month of November 2023, the Company realized a decrease in sales of 20% compared to the same month of the previous year, incl. 11% decrease in domestic sales and 26% decrease in export sales. For the eleven months from the beginning of 2023, sales increased by a total of 14%, incl. a 3% increase in domestic sales and a 21% increase in export sales.
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19